Acrivastine

In the US, Acrivastine (acrivastine/pseudoephedrine systemic) is a member of the drug class antihistamines.

US matches:

• Acrivastine/Pseudoephedrine


• Acrivastine and pseudoephedrine


• Acrivastine/Pseudoephedrine Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R06AX18

CAS registry number (Chemical Abstracts Service)

0087848-99-5

Chemical Formula

C22-H24-N2-O2

Molecular Weight

348

Therapeutic Category

Histamine, H₁-receptor antagonist

Chemical Name

2-Propenoic acid, 3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (E,E)-

Foreign Names

• Acrivastinum (Latin)
• Acrivastin (German)
• Acrivastine (French)
• Acrivastina (Spanish)

Generic Names

• Acrivastine (OS: USAN, DCF, BAN)
• BW 825C (IS: Wellcome)

Brand Names

• Benadryl
  Johnson & Johnson, Finland; McNeil, Denmark; McNeil, Malta



• Duact (Acrivastine and Pseudoephedrine)
  GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland



• Semprex
  EU-Pharma, Netherlands; Eureco, Netherlands; Euro, Netherlands; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Georgia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Iran; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Qatar; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Singapore; GlaxoSmithKline, Turkey; GlaxoSmithKline, South Africa; Pfizer, Estonia; Pfizer, Latvia; Wellcome-GB, Italy



• Semprex-D (Acrivastine and Pseudoephedrine)
  UCB, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.